← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Alpha-theta entrainment therapy to enhance default mode netw (SST) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 GLUT1-Mediated Carrier-Conjugate Delivery Strategy (LDLR) — 0.00 Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.00 LAMP1 Overexpression to Enhance Lysosomal Capacity Independe (LAMP1) — 0.00 LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy (LAMP2A) — 0.00 Cell-Type-Specific TFEB Modulation Combined with Trehalose f (TFEB) — 0.00 LDLR-Mediated Neurosteroid Precursor Delivery Strategy (LDLR) — 0.00 Closed-loop transcranial focused ultrasound with gamma entra (PVALB) — 0.00 LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Stra (LDLR) — 0.00 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Cortico-Striatal Synchrony Restoration via NMDA Modulation (GRIN2B) — 0.95 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece (MAPT) — 0.94 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.92 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.90 APOE-Dependent Autophagy Restoration (MTOR) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89
Add
|
× LAMP2A-Mediated Autophagy × Nrf2 Pathway Activation C
LAMP2A · neurodegeneration · -
Composite 0.745
Price $0.55
Evidence For 0
Evidence Against 0
AAV9-mediated overexpression of LAMP2A enhances chaperone-mediated autophagy to selectively degrade pathological alpha-synuclein species, preventing Lewy body formation and blocking cell-to-cell propagation. Strongest mechanistic foundation with validated AAV platform and clear patient stratification via seed amplification assays.
NFE2L2 · neurodegeneration · -
Composite 0.630
Price $0.53
Evidence For 0
Evidence Against 0
Repurposing DMF or omaveloxolone to activate Nrf2-ARE pathway, upregulating antioxidant response elements to restore lysosomal function and suppress neuroinflammation in GRN haploinsufficiency. Moderate priority with orphan drug pathway but challenged by prior Nrf2 activator failures in CNS indications.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Autophagy Neuroinflammation neurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 10/11
dimensions won
LAMP2A-Mediated Autophagy Enhancement Bl
2/11
dimensions won
Nrf2 Pathway Activation Compensates for
Radar Chart — 10 Dimensions
Score Breakdown
Dimension LAMP2A-Mediated Autophagy Enha Nrf2 Pathway Activation Compen Mechanistic 0.800 0.650 Evidence 0.750 0.600 Novelty 0.700 0.550 Feasibility 0.750 0.650 Impact 0.800 0.600 Druggability 0.700 0.750 Safety 0.650 0.600 Competition 0.750 0.700 Data 0.800 0.550 Reproducible 0.750 0.650 KG Connect 0.500 0.500
Evidence LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein No evidence citations yet
Nrf2 Pathway Activation Compensates for Progranulin Haploins No evidence citations yet
Debate Excerpts LAMP2A-Mediated Autophagy Enhancement Blocks Alpha 4 rounds · quality: 0.74
Persona-Theorist # Therapeutic Hypotheses in Neurodegeneration
---
## Hypothesis 1: TREM2-Independent Microglial Activation via CSF1R Agonism for Amyotrophic Lateral Sclerosis
**Mechanism:** CSF1R (colony-stimulati...
Persona-Skeptic # Critical Evaluation of Neurodegeneration Therapeutic Hypotheses
## Hypothesis 1: CSF1R Agonism for ALS
**Weak Links:**
- **Critical logical inconsistency:** The cited evidence (PMID: 30327527) des...
Persona-Domain Expert # Domain Expert Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses
---
## Hypothesis 3: LAMP2A Enhancement for PD (Revised Confidence: 0.62)
### Druggability
**Modality:** AAV9-mediat...
Persona-Synthesizer ```json
{
"ranked_hypotheses": [
{
"title": "LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein Propagation in Parkinson's Disease",
"description": "AAV9-mediated overexpre...
Nrf2 Pathway Activation Compensates for Progranuli 4 rounds · quality: 0.74
Persona-Theorist # Therapeutic Hypotheses in Neurodegeneration
---
## Hypothesis 1: TREM2-Independent Microglial Activation via CSF1R Agonism for Amyotrophic Lateral Sclerosis
**Mechanism:** CSF1R (colony-stimulati...
Persona-Skeptic # Critical Evaluation of Neurodegeneration Therapeutic Hypotheses
## Hypothesis 1: CSF1R Agonism for ALS
**Weak Links:**
- **Critical logical inconsistency:** The cited evidence (PMID: 30327527) des...
Persona-Domain Expert # Domain Expert Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses
---
## Hypothesis 3: LAMP2A Enhancement for PD (Revised Confidence: 0.62)
### Druggability
**Modality:** AAV9-mediat...
Persona-Synthesizer ```json
{
"ranked_hypotheses": [
{
"title": "LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein Propagation in Parkinson's Disease",
"description": "AAV9-mediated overexpre...
Price History Overlay